Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahnadi, C. E.
Right arrow Articles by Dupuis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahnadi, C. E.
Right arrow Articles by Dupuis, G.
(Journal of Leukocyte Biology. 2000;68:293-300.)
© 2000 by Society for Leukocyte Biology

Chronic PMA treatment of Jurkat T lymphocytes results in decreased protein tyrosine phosphorylation and inhibition of CD3- but not Ti-dependent antibody-triggered Ca2+ signaling

Charaf E. Ahnadi*,{dagger}, Patrick Giguère{ddagger}, Serge Gravel*, Danièle Gagné§, Anne-Christine Goulet§, Tamàs Fülöp, Jr§, Marcel D. Payet{dagger} and Gilles Dupuis*

* Departments of Biochemistry and
{dagger} Physiology and Biophysics,
{ddagger} Clinical Research Center and
§ Centre de Recherche en Gérontologie et Gériatrie, Faculty of Medicine, University of Sherbrooke, Quebec, Canada

Correspondence: Dr. Gilles Dupuis, Department of Biochemistry, Faculty of Medicine, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec, Canada, J1H 5N4. E-mail: gdupui01{at}courrier.usherb.ca

We have treated Jurkat T lymphocytes with a concentration (160 nM) of phorbol myristyl acetate (PMA) that down-regulates conventional and novel protein kinase C (PKC) isozymes and we have investigated the effects on Ca2+ signaling and protein tyrosine phosphorylation using mAb (C305) directed against the ß-subunit of the Ti heterodimer or the {varepsilon}/{delta}-component of the CD3 complex (mAb Leu 4 or OKT 3). The levels of expression of PKC {alpha}, ßI, ßII, and {delta} were reduced by 90% or more in PMA-treated cells, whereas the expression of PKC{theta} decreased by ~30%. In contrast, the chronic treatment with PMA increased the expression of PKC{varepsilon} and PKC{zeta}. There was a lack of Ca2+ response and myo-inositol trisphosphate (IP3) production in PMA-treated cells when they were exposed to mAb Leu 4 but the cells responded to mAb C305. The treatment with PMA did not affect the surface expression of Ti or CD3. The overall levels of tyrosine-phosphorylated proteins were markedly reduced in PMA-treated cells. We investigated whether these observations were related to defects in signal transduction related to protein tyrosine kinase (PTK) of the src and syk families. The electrophoretic mobilities of p59fyn or ZAP-70 were not changed in PMA-treated cells but p56Ick migrated as a large band of Mr 60–62 kDa. The decreased mobility of p56Ick was related to a state of hyperphosphorylation. The activity of modified p56Ick was not up-regulated in activated Jurkat cells. Our data suggest that clonotypic Ti can trigger Ca2+ mobilization independently of conventional PKC isoforms. Our observations further suggest that conventional PKC isoforms are involved early in the cascade of events associated with Jurkat T lymphocyte activation.

Key Words: protein kinase C • down-regulation • phorbol myristyl acetate • signal transduction • protein tyrosine kinase




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. C. Todt, B. Hu, A. Punturieri, J. Sonstein, T. Polak, and J. L. Curtis
Activation of Protein Kinase C beta II by the Stereo-specific Phosphatidylserine Receptor Is Required for Phagocytosis of Apoptotic Thymocytes by Resident Murine Tissue Macrophages
J. Biol. Chem., September 20, 2002; 277(39): 35906 - 35914.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Leukocyte Biology.